These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7619961)

  • 1. [The cell-mediated antiviral immune response. The possible therapeutic implications for chronic hepatitis B viral infection].
    Bertoletti A; Ferrari C; Fiaccadori F
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):33-7. PubMed ID: 7619961
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pattern of T cell activation in absence of protective immunity against hepatitis B virus. Review].
    Goncalves L; Barboza L; Albarrán B; Salmen S; Montes H; Hernández M; Berrueta L
    Invest Clin; 2006 Mar; 47(1):83-96. PubMed ID: 16562647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-cell response against viruses. A new non-cytotoxic antiviral strategy].
    Thimme R; Blum HE
    Dtsch Med Wochenschr; 1998 Aug; 123(34-35):1007-8. PubMed ID: 9739766
    [No Abstract]   [Full Text] [Related]  

  • 9. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection.
    Jung MC; Hartmann B; Gerlach JT; Diepolder H; Gruber R; Schraut W; Grüner N; Zachoval R; Hoffmann R; Santantonio T; Wächtler M; Pape GR
    Virology; 1999 Sep; 261(2):165-72. PubMed ID: 10497102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune lesion of hepatitis B].
    García Buey L; González Mateos F; García Monzón C; Moreno Otero R
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():15-28. PubMed ID: 11279891
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B virus: from immunobiology to immunotherapy.
    Grimm D; Heeg M; Thimme R
    Clin Sci (Lond); 2013 Jan; 124(2):77-85. PubMed ID: 23013042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Action mechanism in immunopathogenesis and clearance of HBV].
    Im SJ; Sung YC
    Korean J Hepatol; 2006 Jun; 12(2):154-62. PubMed ID: 16804340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the study of liver disease and immune abnormalities. a. Viral hepatitis].
    Nagashima H
    Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):755-9. PubMed ID: 6387009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic hepatitis B. Relations between hepatitis virus and the immunological response].
    Bianchi L; Singelsen M; Stalder GA; Gudat YF
    Rev Clin Esp; 1979 Mar; 152(6):439-45. PubMed ID: 472398
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
    Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
    Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenesis: role of innate and adaptive immune responses.
    Visvanathan K; Lewin SR
    Semin Liver Dis; 2006 May; 26(2):104-15. PubMed ID: 16673289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunopathogenesis of HBV infection.
    Koziel MJ
    Antivir Ther; 1998; 3(Suppl 3):13-24. PubMed ID: 10726052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on interferon-gamma (IFN-gamma) response by T cells stimulated by hepatitis B virus core antigen.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Apr; 30(1):9-15. PubMed ID: 15376464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The race between infection and immunity: how do pathogens set the pace?
    Davenport MP; Belz GT; Ribeiro RM
    Trends Immunol; 2009 Feb; 30(2):61-6. PubMed ID: 19138564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.